Mindray Medical International Limited (NYSE:MR)

CAPS Rating: 3 out of 5

The Company is a developer, manufacturer and marketer of medical devices in China.

Results 1 - 20 of 184 : 1 2 3 4 5 6 7 8 9 10 Next »

Recs

0
Member Avatar FrankoJames (94.58) Submitted: 12/12/2014 8:41:58 AM : Outperform Start Price: $29.30 MR Score: -7.54

The potential GE of China.

Recs

0
Member Avatar OklaBoston (68.16) Submitted: 11/16/2014 5:01:02 PM : Underperform Start Price: $31.10 MR Score: +13.07

Downtrended stock I would pay no more than $14 for barring earnings surprises.

Recs

0
Member Avatar CMCassociates (69.05) Submitted: 11/7/2013 8:10:17 PM : Outperform Start Price: $35.50 MR Score: -40.13

From the value investor's perspective, Mindray stands out as a reliably impressive performer considering its ROE, ROA, 5 year trailing earnings growth, and quick ratio. MR touts its improved cash conversion cycle as a strength; indeed, my observations of its ROE, 5 year trailing earnings growth > 23%, and quick ratio also reveal strong internal management.

Recs

0
Member Avatar Marlonito9 (< 20) Submitted: 9/11/2013 7:29:25 AM : Outperform Start Price: $40.92 MR Score: -54.37

This business group is too valuable specially in the field of medicines not to able to outperform the S&P 500 in a whole year period. On time past, it outperform the index between February and August many times. It will do the same over future periods since Chinese Medicinal technology is already proven high integrity.

Recs

0
Member Avatar BrentonKJ (26.85) Submitted: 7/15/2013 3:47:20 PM : Outperform Start Price: $33.84 MR Score: -35.69

Great growth prospects. I don't see why this one isn't getting bought out.

Recs

0
Member Avatar MASTERHF (< 20) Submitted: 8/19/2012 10:37:11 PM : Outperform Start Price: $34.62 MR Score: -64.95

Mindray will outperform the market because it developed a "marubozu" candle, on massive volume, this month and it's going higher (https://sites.google.com/site/higheralphaideas/home/combiningfundamentalsandtechnicalstoproducesuperiorresults).
A bullish marubozu candle shows buying interest the entire trading day. There are either no tails (shadows) or very small tails on the candle. It opens with a gap up and the buying interest never slows, trending higher all session long and finishing at or very near its high of the day.

Recs

0
Member Avatar phatchips767 (< 20) Submitted: 2/22/2012 6:33:21 PM : Outperform Start Price: $27.87 MR Score: -52.56

chinese stock rated #13 top rated world stocks.

Recs

0
Member Avatar frederick7 (< 20) Submitted: 2/22/2011 3:01:06 PM : Outperform Start Price: $24.87 MR Score: -45.59

This company is in the right place at the right time

Recs

0
Member Avatar RoboInvestor5000 (< 20) Submitted: 1/27/2011 11:22:47 AM : Outperform Start Price: $24.89 MR Score: -48.38

(JJ) Good earnings growth, well positioned to continue growing in an emerging market. Credible accounting.

Recs

0
Member Avatar DrRonPaul4Prez (64.93) Submitted: 12/2/2010 6:44:13 PM : Outperform Start Price: $24.77 MR Score: -57.34

With PricewaterhouseCoopers as its audit firm, there's much less of a concern about the integrity of the financial reports as is the case with other China based companies. I see this stock doing well when China stocks swing in favor. And I am putting my money where my mouth is...I invested today...this takes the China spot in my portfolio.

Recs

0
Member Avatar firestargal (< 20) Submitted: 12/2/2010 9:44:46 AM : Outperform Start Price: $25.18 MR Score: -59.86

oversold.

Recs

0
Member Avatar quietnews (< 20) Submitted: 12/1/2010 11:37:23 AM : Outperform Start Price: $24.97 MR Score: -59.63

I'm in China often. The level of medical care needs strong infrastructure improvement, including equipment. I'm surprised the China government hasn't put this as one of their very high priorities. MR will be poised to take advantage when this focus happens.

Recs

1
Member Avatar mrindependent (36.30) Submitted: 11/18/2010 12:13:33 PM : Outperform Start Price: $26.57 MR Score: -67.26

After adjusting the share price downward to reflect the company's net cash position of $3.70 per share, I calculate that Mindray Medical is selling for about 14 times its forward eps. Considering this company's impressive operations history and outstanding growth prospects as a Chinese maker of medical devices, this seems like a deal. The auditor is Price Waterhouse Coopers - so not much chance of fraud.

Recs

1
Member Avatar pburns1587 (< 20) Submitted: 10/26/2010 11:35:44 AM : Outperform Start Price: $27.89 MR Score: -74.40

Paying off debt, rising sales, constant profit growth.

Recs

1
Member Avatar hammyttu (24.76) Submitted: 9/29/2010 9:41:36 PM : Outperform Start Price: $27.17 MR Score: -77.35

Stock screen results. Using ROE, PE, LT debt/Equity, Current Ratio.

Recs

0
Member Avatar cherrera (< 20) Submitted: 7/1/2010 3:28:31 PM : Outperform Start Price: $23.65 MR Score: -53.17

you know why.....

Recs

0
Member Avatar Roni13 (37.46) Submitted: 5/20/2010 12:23:46 PM : Outperform Start Price: $27.66 MR Score: -89.44

another good chinese story in healthcare

Recs

0
Member Avatar viki2008 (48.58) Submitted: 4/26/2010 3:35:34 AM : Outperform Start Price: $36.98 MR Score: -93.34

gh

Recs

1
Member Avatar iddqkfyou (< 20) Submitted: 3/17/2010 5:56:05 PM : Outperform Start Price: $33.53 MR Score: -109.67

Chinese medical equipment supplier. I am going to hold my breath and not buy into the stereotype that everything made in China is bad. As the median age continues to increase, Chinese are going to have to spend their savings on something, and it is as likely to be medical care as education.

Recs

0
Member Avatar leomoon (< 20) Submitted: 2/26/2010 10:06:49 AM : Outperform Start Price: $35.24 MR Score: -106.77

Looking for "THE" China Play

Featured Broker Partners


Advertisement